+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

NGS Sample Preparation Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 183 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5788870
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

As next generation sequencing (NGS) technologies accelerate, senior leaders in pharmaceuticals, diagnostics, and laboratory operations face critical choices in sample preparation workflows. The NGS sample preparation market is evolving rapidly, with efficiency, automation, and regulatory adherence emerging as central decision drivers that influence competitive advantage and organizational resilience.

Market Snapshot: NGS Sample Preparation Market Growth Outlook

The NGS sample preparation market continues on a solid growth trajectory, driven by broadening adoption in both research and clinical settings. Forecasts indicate an increase in market value from USD 2.78 billion in 2024 to USD 3.24 billion in 2025, reaching USD 9.45 billion by 2032. This momentum reflects increased uptake of next generation sequencing and the expansion of actionable genomic applications. As a result, end users are demanding more automated, high-throughput sample preparation processes with robust accuracy and flexibility to address diverse needs. The rising expectations for streamlined workflows underscore the importance of modular solutions and operational agility in supporting long-term market expansion.

Scope & Segmentation: NGS Sample Preparation Market

This executive-focused report delivers comprehensive, actionable analysis across the NGS sample preparation market to empower informed strategic decision-making. Industry segmentation covers the following core categories:

  • Product Types: Includes amplification kits encompassing PCR, digital PCR, qPCR, and rolling circle amplification; fragmentation and size selection kits using enzymatic and mechanical methods; RNA and DNA library preparation solutions; and target enrichment products tailored to various genomic applications.
  • Applications: Addresses epigenetic research, metagenomics, a spectrum of RNA sequencing formats such as mRNA, small RNA, total RNA, and miRNA, along with oncology, inherited disease screening, and pharmacogenomics workflows.
  • Technologies: Details magnetic and solid phase bead-based methods, enzymatic processing, microfluidic solutions including droplet and lab-on-chip platforms, and established PCR-driven approaches.
  • Workflow Steps: Maps the full process, from amplification and enrichment to fragmentation, library construction, quantification, and quality assurance.
  • End Users: Involves academic and government research centers, contract research organizations, diagnostics laboratories, and pharmaceutical and biotechnology companies with scalable, high-throughput processing needs.
  • Regions: Analyzes the Americas (North and Latin America), Europe, Middle East, Africa, and Asia-Pacific, highlighting localized operational drivers and regulatory environments affecting adoption and supplier collaboration.
  • Leading Companies: Provides detailed profiles on Illumina, Thermo Fisher Scientific, QIAGEN, Roche Diagnostics, Agilent Technologies, New England Biolabs, Takara Bio, PerkinElmer, Bio-Rad Laboratories, Promega, Merck KGaA, BGI Genomics, Sysmex, and Novogene.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Consistent and efficient NGS sample preparation is essential to achieve reliable sequencing outcomes and support reproducibility across research and diagnostics initiatives.
  • Embracing automation and modular products supports rapid adjustments in laboratory throughput and allows organizations to respond effectively to changing workflow demands and project scales.
  • Technologies such as digital PCR and integrated microfluidic platforms broaden potential for advanced genomic analysis, particularly with low-input or single-cell samples.
  • Supply chain resilience is a top priority, prompting organizations to adopt adaptive logistics and sourcing models to mitigate risks from raw material and reagent variability.
  • Strategic industry alliances and technology partnerships are shaping speed-to-market and facilitating regulatory compliance, particularly in regions with evolving requirements.
  • Regional diversity in funding structures, regulatory policies, and healthcare priorities requires tailored procurement strategies and technology choices for optimal performance and compliance.

Tariff Impact on the NGS Sample Preparation Ecosystem

Planned United States tariffs commencing in 2025 introduce new challenges for NGS sample preparation supply chains. Organizations face increased import costs, extended delivery times, and pricing volatility, leading many to reassess procurement strategies, regional manufacturing, and supplier diversification to maintain workflow continuity and competitive positioning.

Methodology & Data Sources

This report utilizes a rigorous methodology, including direct interviews with industry executives, feedback from leading solution providers and key end users, and validation through secondary datasets and patent reviews. Oversight by subject matter experts further ensures the findings are relevant and actionable for leaders.

Why This Report Matters

  • Enables executive benchmarking of technology adoption and sample preparation practices, supporting optimized operational and purchasing decisions for NGS workflows.
  • Empowers leaders to proactively identify and address supply chain vulnerabilities, regulatory risks, and regional adoption challenges, ensuring operational continuity.
  • Presents structured, segment-level analysis of product offerings, technology developments, and competitor positioning to inform both strategic planning and successful market entry or expansion.

Conclusion

Senior decision-makers can gain actionable insights from this report to guide both strategic planning and operational agility within the dynamic NGS sample preparation ecosystem. Leverage this analysis to drive data-supported growth and improve resilience in a complex, rapidly changing market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of microfluidic platforms for automated single-cell NGS library preparation to enhance throughput and reduce reagent usage
5.2. Adoption of enzymatic fragmentation kits for streamlined DNA shearing and improved sequencing uniformity in NGS workflows
5.3. Development of magnetic bead-based cleanup systems for high-throughput, scalable NGS library purification and precise size selection
5.4. Implementation of robotics-driven end-to-end NGS sample prep solutions to minimize manual error and accelerate turnaround times
5.5. Emergence of barcoded transposase-based tagmentation methods for cost-effective multiplexed NGS library construction
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. NGS Sample Preparation Market, by Product Type
8.1. Amplification Kits
8.1.1. Pcr Kits
8.1.1.1. Conventional Pcr Kits
8.1.1.2. Digital Pcr Kits
8.1.1.3. Qpcr Kits
8.1.2. Rolling Circle Amplification
8.1.2.1. Padlock Probe Based
8.1.2.2. Phi29 Based
8.2. Fragmentation and Size Selection
8.2.1. Enzymatic Fragmentation
8.2.1.1. Endonuclease Based
8.2.1.2. Transposase Based
8.2.2. Mechanical Fragmentation
8.2.2.1. Bioruptor
8.2.2.2. Covaris
8.3. Library Prep Kits
8.3.1. Rna Library Prep
8.3.1.1. Mrna Kits
8.3.1.2. Small Rna Kits
8.3.1.3. Total Rna Kits
8.3.2. Targeted Library Prep
8.3.2.1. Inherited Disease Panels
8.3.2.2. Oncology Panels
8.3.3. Whole Genome Library Prep
8.3.3.1. Pcr-free Kits
8.3.3.2. Standard Wgs Kits
8.4. Target Enrichment Kits
8.4.1. Amplicon Enrichment
8.4.1.1. Multiplex Pcr
8.4.1.2. Singleplex Pcr
8.4.2. Hybridization Capture
8.4.2.1. Array Based
8.4.2.2. Solution Based
9. NGS Sample Preparation Market, by Application
9.1. Epigenetics
9.1.1. Bisulfite Sequencing
9.1.2. Chip Sequencing
9.2. Metagenomics
9.2.1. 16s Rrna Sequencing
9.2.2. Shotgun Metagenomics
9.3. Rna Sequencing
9.3.1. Mirna Sequencing
9.3.2. Mrna Sequencing
9.3.3. Total Rna Sequencing
9.4. Targeted Sequencing
9.4.1. Inherited Disease
9.4.2. Oncology
9.4.3. Pharmacogenomics
9.5. Whole Genome Sequencing
10. NGS Sample Preparation Market, by Technology
10.1. Bead Based
10.1.1. Magnetic Beads
10.1.2. Solid Phase Beads
10.2. Enzyme Based
10.2.1. Ligase
10.2.2. Restriction Enzyme
10.2.3. Transposase
10.3. Microfluidics
10.3.1. Droplet Based
10.3.2. Lab On Chip
10.4. Pcr Based
10.4.1. Conventional Pcr
10.4.2. Digital Pcr
10.4.3. Qpcr
11. NGS Sample Preparation Market, by Workflow Step
11.1. Amplification
11.1.1. Pcr Amplification
11.1.2. Rolling Circle
11.2. Enrichment
11.2.1. Amplicon
11.2.2. Hybridization
11.3. Fragmentation
11.3.1. Enzymatic
11.3.2. Mechanical
11.4. Library Preparation
11.4.1. Rna Prep
11.4.2. Targeted Prep
11.4.3. Wgs Prep
11.5. Quantification and QC
11.5.1. Electrophoretic
11.5.2. Fluorometric
12. NGS Sample Preparation Market, by End User
12.1. Academic and Government
12.2. Contract Research Organizations
12.3. Diagnostic Laboratories
12.4. Pharma and Biotech
13. NGS Sample Preparation Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. NGS Sample Preparation Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. NGS Sample Preparation Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Illumina, Inc.
16.3.2. Thermo Fisher Scientific Inc.
16.3.3. QIAGEN N.V.
16.3.4. Roche Diagnostics International Ltd.
16.3.5. Agilent Technologies, Inc.
16.3.6. New England Biolabs, Inc.
16.3.7. Takara Bio Inc.
16.3.8. PerkinElmer, Inc.
16.3.9. Bio-Rad Laboratories, Inc.
16.3.10. Promega Corporation
16.3.11. Merck KGaA
16.3.12. BGI Genomics Co., Ltd.
16.3.13. Promega Corporation
16.3.14. Sysmex Corporation
16.3.15. Novogene Co., Ltd.
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this NGS Sample Preparation market report include:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Roche Diagnostics International Ltd.
  • Agilent Technologies, Inc.
  • New England Biolabs, Inc.
  • Takara Bio Inc.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Promega Corporation
  • Merck KGaA
  • BGI Genomics Co., Ltd.
  • Promega Corporation
  • Sysmex Corporation
  • Novogene Co., Ltd.

Table Information